{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:29:28Z","timestamp":1790206168532,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.antiviral.2010.02.004","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T09:27:24Z","timestamp":1265966844000},"page":"137-143","source":"Crossref","is-referenced-by-count":14,"title":["Effect of ritonavir and atazanavir on human subcutaneous preadipocyte proliferation and differentiation"],"prefix":"10.1016","volume":"86","author":[{"given":"Giuseppe","family":"Caso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izolda","family":"Mileva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Mcnurlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C.","family":"Mynarcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Darras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Gelato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2010.02.004_bib1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2010.02.004_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/14787210.1.3.403","article-title":"Atazanavir: improving the HIV protease inhibitor class","volume":"1","author":"Becker","year":"2003","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.antiviral.2010.02.004_bib3","first-page":"936","article-title":"Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing","volume":"47","author":"Carmichael","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2010.02.004_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.antiviral.2010.02.004_bib5","doi-asserted-by":"crossref","first-page":"507141","DOI":"10.1155\/2009\/507141","article-title":"Antiretroviral-related adipocyte dysfunction and lipodystrophy in HIV-infected patients: alteration of the PPARgamma-dependent pathways","volume":"2009","author":"Caron","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.antiviral.2010.02.004_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/CS20040096","article-title":"Tumour cell growth in culture: dependence on arginine","volume":"107","author":"Caso","year":"2004","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.antiviral.2010.02.004_bib7","doi-asserted-by":"crossref","first-page":"41325","DOI":"10.1074\/jbc.M006474200","article-title":"Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors","volume":"275","author":"Dowell","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2010.02.004_bib8","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1128\/MCB.19.8.5495","article-title":"Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1\/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism","volume":"19","author":"Fajas","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2010.02.004_bib9","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1097\/00002030-199910220-00011","article-title":"The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring","volume":"13","author":"Gatti","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2010.02.004_bib10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1055\/s-2005-870526","article-title":"The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes","volume":"37","author":"Grigem","year":"2005","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.antiviral.2010.02.004_bib11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/00002030-200404090-00016","article-title":"Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir","volume":"18","author":"Haerter","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2010.02.004_bib12","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI114345","article-title":"Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium","volume":"84","author":"Hauner","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2010.02.004_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(01)00148-6","article-title":"Metabolic complications associated with antiretroviral therapy","volume":"51","author":"Jain","year":"2001","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.02.004_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2010.02.004_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/oby.2003.11","article-title":"Human mesenchymal stem cells as an in vitro model for human adipogenesis","volume":"11","author":"Janderov\u00e1","year":"2003","journal-title":"Obes. Res."},{"key":"10.1016\/j.antiviral.2010.02.004_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/498505","article-title":"Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients","volume":"42","author":"Jemsek","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.02.004_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/QAD.0b013e3283021a4f","article-title":"Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes","volume":"22","author":"Jones","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2010.02.004_bib18","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/oby.2006.114","article-title":"HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism","volume":"14","author":"Kim","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.antiviral.2010.02.004_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.med.55.091902.104412","article-title":"HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies","volume":"55","author":"Koutkia","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.antiviral.2010.02.004_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2010.02.004_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biochi.2004.12.007","article-title":"HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo","volume":"87","author":"Lagathu","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.antiviral.2010.02.004_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(00)00102-9","article-title":"HIV protease inhibitors block adipogenesis and increase lipolysis in vitro","volume":"47","author":"Lenhard","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2010.02.004_bib23","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1152\/ajpendo.00206.2003","article-title":"Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels","volume":"285","author":"Lihn","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.antiviral.2010.02.004_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.antiviral.2010.02.004_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med."},{"key":"10.1016\/j.antiviral.2010.02.004_bib26","first-page":"174","article-title":"Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia","volume":"39","author":"M\u00f6bius","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2010.02.004_bib27","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00126334-200212150-00009","article-title":"Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution","volume":"31","author":"Mynarcik","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2010.02.004_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/10409230591008189","article-title":"Adipose development: from stem cell to adipocyte","volume":"40","author":"Otto","year":"2005","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.antiviral.2010.02.004_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00002030-200201040-00003","article-title":"Effects of antiretroviral drug combinations on the differentiation of adipocytes","volume":"16","author":"Roche","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2010.02.004_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-201X.2004.01383.x","article-title":"Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors","volume":"183","author":"Rudich","year":"2005","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.antiviral.2010.02.004_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/QAI.0b013e3181a5701c","article-title":"Improvement in lipid profiles in antiretroviral-experienced HIV-positive patients with hyperlipidemia after a switch to unboosted atazanavir","volume":"51","author":"Sension","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2010.02.004_bib32","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/FTD.0b013e3181897bff","article-title":"Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients","volume":"30","author":"Solas","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.antiviral.2010.02.004_bib33","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/jc.2002-021922","article-title":"Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy","volume":"88","author":"Sutinen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.antiviral.2010.02.004_bib34","doi-asserted-by":"crossref","first-page":"R1286","DOI":"10.1152\/ajpregu.00653.2001","article-title":"Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes","volume":"282","author":"Tchkonia","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.antiviral.2010.02.004_bib35","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1074\/jbc.M408687200","article-title":"Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines","volume":"280","author":"Vernochet","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2010.02.004_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0021-9258(17)37913-9","article-title":"Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cells","volume":"254","author":"Wise","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2010.02.004_bib37","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1210\/jc.84.11.4274","article-title":"Inhibition of adipocyte differentiation by HIV protease inhibitors","volume":"84","author":"Zhang","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T06:32:18Z","timestamp":1685428338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0166354210000331"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.02.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}